Vol 72, No 3 (2021)
Clinical vignette
Published online: 2021-04-08

open access

Page views 1262
Article views/downloads 676
Get Citation

Connect on Social Media

Connect on Social Media

Type 3 autoimmune polyglandular syndrome with multiple genetic alterations in a young male patient with type 1 diabetes mellitus

Abel Decmann1, Judit Tőke1, Éva Csöregh2, Géza Gáspárdy2, Anikó Somogyi2
Pubmed: 34010447
Endokrynol Pol 2021;72(3):286-287.


Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file


  1. Mayer-Davis EJ, Kahkoska AR, Jefferies C, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018; 19 Suppl 27: 7–19.
  2. Morawiec-Szymonik E, Foltyn W, Marek B, et al. Pernicious anaemia and endocrine glands antibodies. Endokrynol Pol. 2019; 70(2): 143–150.
  3. Zalawadiya SK, Veeranna V, Mallikethi-Reddy S, et al. Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol. 2011; 58(10): 1025–1033.
  4. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000; 151(9): 862–877.
  5. Clarke R, Bennett DA, Parish S, et al. MTHFR Studies Collaborative Group. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med. 2012; 9(2): e1001177.